<DOC>
	<DOCNO>NCT02694848</DOCNO>
	<brief_summary>To evaluate therapeutic evaluation combination therapy aspirin salvianolate injection base population pharmacokinetics TEG.A prospective , multicenter , randomize , control clinical trial used.A total 120 patient recruit divided three group , respectively salvianolate injection group , aspirin group salvianolate injection aspirin group，and course treatment 10 day .</brief_summary>
	<brief_title>Clinical Study Combination Therapy Angina Coronary Heart Disease With Aspirin Salvianolate Injection</brief_title>
	<detailed_description>1 . Effectiveness evaluation : Primary Outcome Measure : Change TEG（R time , K time , α angle , MA , CI , TPI）.Secondary Outcome Measures : Change symptom score Seattle Angina Questionnaiire ( SAQ ) .Change ECG abnormalities.Change score traditional Chinese medicine ( TCM ) symptom curative effect rating scale . Change platelet aggregation measure light transmittance aggregometry ( LTA ) .Change serum lipids（TC、TG、HDL-C、LDL-C）.Change fasting blood glucose.Population pharmacokinetics test ( detection blood concentration magnesium lithospermate B salicylic acid ) . 2 . Safety evaluation : Change PT , APTT , TT , FIB.Adverse events.Change basic life sign.Gastrointestinal symptoms.Change stool routine.Change routine blood test.Change urine routine.Change liver function.Change renal function.Change fecal occult blood . 3 . Number participants:120 participant divide three group , salvianolate group ( n=40 ) , aspirin group ( n=40 ) combination therapy group salvianolate injection aspirin ( n=40 ) . 4 . Interventions : salvianolate injection group : salvianolate injection , intravenously infusion,0.2g/time , day ; routine treatment accord condition disease.Aspirin group : aspirin , oral administration method,0.1g/time , day ; routine treatment accord condition disease.Salvianolate injection aspirin group : salvianolate injection , intravenously infusion,0.2g/time , day ; aspirin , oral administration method,0.1g/time , day ; routine treatment accord condition disease . 5 . Course treatment：10 day .</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Angina Pectoris</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<criteria>Patient age 3575 year old Grade II diagnostic criterion chronic stable angina pectoris Diagnostic criterion blood stasis type Signed informed consent Drug allergy test There family personal history hemorrhagic disease Platelet count &lt; 100 * nine time square 10/L &gt; 450 *nine time square 10/L Hemoglobin &lt; 90g/L ALT , AST high upper limit 2 time , BUN , Cr high upper limit Drugs use clopidogrel , clopidogrel , Hua Falin heparin last 2 week take blood circulation drug antiplatelet , anticoagulant non steroidal antiinflammatory drug Heart failure three degree , two degree patient heart failure A history trauma surgery past 2 week Combined coronary heart disease myocardial infarction cerebral blood vessel , liver , kidney , hematopoietic system severe primary disease , malignant tumor , mental disease patient , well hyperthyroidism , cervical spondylosis , stomach esophageal reflux patient chest pain Organ transplantation , AIDS , longterm use immunosuppressive agent immune deficiency Pregnant lactate woman Other clinical trial participant take part evaluation result study</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>